Semaglutide Significantly Slows Biological Aging, Clinical Trial Shows
A breakthrough study reveals that semaglutide can significantly reverse markers of biological and cellular aging.
Read AnalysisPopular Diabetes Drugs Linked to Better Breast Cancer Survival
A massive retrospective study suggests that GLP-1 receptor agonists may dramatically lower mortality and recurrence rates for breast cancer patients with obesity or type 2 diabetes.
Read AnalysisSemaglutide May Boost Motivation in People With Depression
A new clinical trial suggests semaglutide could help overcome the paralyzing lack of motivation often caused by major depressive disorder.
Read AnalysisTirzepatide Outperforms Dulaglutide for Heart and Kidney Protection
A major clinical trial reveals that tirzepatide offers superior protection against heart and kidney complications compared to a standard GLP-1 therapy.
Read AnalysisCan Semaglutide Help You Quit Smoking? What Science Says
A new clinical trial explores whether the popular weight-loss drug semaglutide could also help curb nicotine cravings and reduce smoking.
Read AnalysisGLP-1 Drug Semaglutide Fails to Slow Early Alzheimer's
A major phase 3 trial reveals that oral semaglutide does not slow cognitive decline in patients with early-stage Alzheimer's disease.
Read AnalysisSemaglutide Effectively Treats Severe Fatty Liver Without Invasive Biopsies
A new clinical trial shows semaglutide significantly reduces liver fat and inflammation, and these improvements can be tracked using non-invasive scans instead of painful biopsies.
Read AnalysisBeyond Weight Loss: What GLP-1 Drugs Do to Your Body
While GLP-1 medications are famous for treating diabetes, a massive new study reveals how they impact everything from your gut to your lungs.
Read AnalysisStaying on Tirzepatide Keeps the Weight Off, Study Shows
A major clinical trial reveals what happens when you stop, lower, or maintain your dose of tirzepatide after losing weight.
Read Analysis